Addus HomeCare Co. (NASDAQ:ADUS) Shares Purchased by Vestcor Inc

Vestcor Inc increased its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 58.0% in the fourth quarter, Holdings Channel reports. The firm owned 4,150 shares of the company’s stock after buying an additional 1,524 shares during the quarter. Vestcor Inc’s holdings in Addus HomeCare were worth $520,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently bought and sold shares of the business. Summit Place Financial Advisors LLC boosted its stake in Addus HomeCare by 0.9% during the 4th quarter. Summit Place Financial Advisors LLC now owns 9,410 shares of the company’s stock worth $1,180,000 after purchasing an additional 80 shares during the period. Janney Montgomery Scott LLC lifted its stake in shares of Addus HomeCare by 0.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company’s stock worth $1,340,000 after acquiring an additional 91 shares during the period. Royce & Associates LP lifted its stake in shares of Addus HomeCare by 1.2% in the 3rd quarter. Royce & Associates LP now owns 8,924 shares of the company’s stock worth $1,187,000 after acquiring an additional 109 shares during the period. Assetmark Inc. lifted its stake in shares of Addus HomeCare by 11.5% in the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock worth $156,000 after acquiring an additional 121 shares during the period. Finally, Parkside Financial Bank & Trust lifted its stake in shares of Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after acquiring an additional 148 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insider Transactions at Addus HomeCare

In other news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the completion of the sale, the chief executive officer now directly owns 79,397 shares in the company, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 4.60% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Stephens reiterated an “overweight” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. Macquarie reiterated an “outperform” rating and issued a $129.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 27th. Finally, Oppenheimer raised their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $132.78.

Check Out Our Latest Stock Analysis on Addus HomeCare

Addus HomeCare Trading Down 0.6 %

NASDAQ:ADUS opened at $90.28 on Monday. The company has a market capitalization of $1.64 billion, a P/E ratio of 20.66, a price-to-earnings-growth ratio of 1.41 and a beta of 0.97. Addus HomeCare Co. has a twelve month low of $87.88 and a twelve month high of $136.72. The firm has a 50-day moving average price of $115.30 and a two-hundred day moving average price of $123.17.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last issued its quarterly earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million for the quarter, compared to analysts’ expectations of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. On average, equities research analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

See Also

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.